Keratitis clinical trials
The registry lists 127 studies for Keratitis across more than 10 countries. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-07-14.
Status
- Completed
- 66
- Status unknown
- 25
- Recruiting
- 11
- Terminated
- 10
- Withdrawn
- 8
- Not yet recruiting
- 4
Phase
- Phase 3
- 21
- Phase 2
- 19
- Phase 4
- 10
- Phase 1
- 7
- Early Phase 1
- 3
Where
- United States
- 38
- France
- 17
- China
- 12
- India
- 9
- Egypt
- 8
- United Kingdom
- 6
Who runs them
National Eye Institute (NEI) (4) · University of California, San Francisco (4) · National Taiwan University Hospital (3) · Shanghai BDgene Co., Ltd. (3) · Assiut University (3) · Santen SAS (3) · Minia University (2) · University Hospital, Strasbourg, France (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 127 — search for more.
- Clinical Predictors of Visual Outcome in Patients Affected With Ocular Surface DiseasesNot yet recruitingNCT076948171 country
- Pattern of Microbial Keratitis in Assiut University HospitalNot yet recruitingNCT07316244
- Complex Ocular Infection, Optimization of Microbiological DiagnosisRecruitingNCT054323361 country
- A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal KeratitisRecruitingNCT06474442Phase 21 country
- Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune DiseaseRecruitingNCT06964269Phase 41 country
- Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-LinkingRecruitingNCT03918408Phase 11 country
- Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic KeratitisRecruitingNCT05927428Phase 21 country
- Use of a New Method for the Microbiological Diagnosis of Severe Corneal InfectionRecruitingNCT058889871 country
- Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial KeratitisRecruitingNCT06451172Early Phase 11 country
- Acanthamoeba and Artificial IntelligenceNot yet recruitingNCT06332703
- Non-invasive Diagnostics of Microbial KeratitisRecruitingNCT063648781 country
- Evaluation of Next-Generation Sequencing-based Metabarcoding Versus Culturing for Microbiological Assessment in Infectious KeratitisRecruitingNCT051839061 country
- Validation of Interleukins and Other Cytokines Together With OCT Imaging for Rapid Infectious Keratitis AssessmentRecruitingNCT056202641 country
- Automated Quantitative Ulcer Analysis StudyRecruitingNCT044209622 countries
- Pack Cross Linking for Infectious KeratitisNot yet recruitingNCT05881187Not applicable1 country
- Mycotic Antimicrobial Localized Injection for Treatment of Corneal UlcersCompletedNCT02731638Phase 32 countries
- OCS-01 in Treating Inflammation and Pain in Post-cataract PatientsCompletedNCT04130802Phase 21 country
- Cross-linking for Corneal Ulcers Treatment TrialCompletedNCT02570321Phase 32 countries
- Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment StructuresCompletedNCT03461978Not applicable1 country
- 3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or KeratoconjunctivitisActive, not recruitingNCT04685109Not applicable1 country
- A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal KeratitisActive, not recruitingNCT06474416Phase 11 country
- REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult PatientsCompletedNCT04276558Phase 27 countries
- The Role of Adjuvant Corneal Crosslinking in the Management of Infective KeratitisCompletedNCT06967376Early Phase 11 country
- DOMPE -MT Neurotrophic KeratitisActive, not recruitingNCT06947850Phase 41 country
- Corneal Nerves After Treatment With CenegerminCompletedNCT046275711 country
- Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic KeratitisWithdrawnNCT02707120Phase 41 country
- Steroids and Cross-linking for Ulcer TreatmentCompletedNCT04097730Phase 32 countries
- Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry EyeTerminatedNCT063646571 country
- Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic KeratitisCompletedNCT06757907Not applicable1 country
- The Effects of a Large Language Model on Clinical Questioning SkillsCompletedNCT06229379Not applicable1 country
- Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant KeratitisTerminatedNCT05250583Phase 21 country
- Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning PositionCompletedNCT04213885Phase 21 country
- 3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)CompletedNCT04144413Phase 37 countries
- Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic KeratitisCompletedNCT05720715Phase 41 country
- The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU PatientsCompletedNCT06539663Phase 2/31 country
- Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.CompletedNCT01756456Phase 1/26 countries
- Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe KeratitisCompletedNCT03237936Phase 41 country
- Wharton's Jelly Eye Drops in the Treatment of Chronic KeratitisCompletedNCT05200000Phase 11 country
- Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.WithdrawnNCT05321251Phase 2/31 country
- The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort StudyCompletedNCT056556891 country
- Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide StudyCompletedNCT055387931 country
- Besifloxacin in Bacterial KeratitisCompletedNCT02497365Not applicable1 country
- Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba KeratitisCompletedNCT03274895Phase 33 countries
- AONDA Therapeutic Indication Study ICompletedNCT058911061 country
- Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious GermsCompletedNCT02819232Not applicable1 country
- Corneal Neurotization as a Treatment for Neurotrophic KeratopathyTerminatedNCT05809245Not applicable1 country
- Role of Anterior Segment Optical Coherence Tomography in Infectious KeratitisCompletedNCT049696401 country
- Ozone-based Eye Drops as Adjuvant Therapy in Microbial KeratitisStatus unknownNCT05689996Phase 3
- Cross-linking as Treatment in Infectious KeratitisCompletedNCT04383431Not applicable1 country
- Investigation of the Microbiome of the Cornea in Microbial KeratitisCompletedNCT040304031 country